Profile data is unavailable for this security.
About the company
Trinity Biotech PLC is an Ireland-based develops, acquires, manufactures and markets medical diagnostic systems, including both reagents and instrumentation for the clinical laboratory and point-of-care segments of the diagnostic market. The Company's products are used to detect autoimmune, infectious and sexually transmitted diseases, diabetes and disorders of the liver and intestine. Its segments include the Americas and Rest of World. It is a provider of raw materials to the life sciences and research industries globally. It also operates a licensed reference laboratory that specializes in diagnostics for autoimmune diseases. Its POC brands include Uni-Gold, Recombigen, MarDx, FlexTrans, Premier and Ultra. Its clinical laboratory brands include ImmuBlot, ImmuGlo, ImmuLisa, OTOblot and EZ. The Company manufactures kits for the detection of specialty and esoteric biomarkers of infectious diseases and other associated laboratory products.
- Revenue in USD (TTM)58.65m
- Net income in USD-22.29m
- Incorporated1992
- Employees380.00
- LocationTrinity Biotech PLCIda Business ParkBray, Co Wicklow, IrelandBRAY 18IrelandIRL
- Phone+353 12769800
- Fax+353 12769888
- Websitehttps://www.trinitybiotech.com/
More ▼
Mergers & acquisitions
| Acquired company | TRIB:NSQ since announced | Transaction value |
|---|---|---|
| Waveform Technologies Inc-Continuous Glucose Monitoring Assets | -41.47% | 21.50m |
Data delayed at least 15 minutes, as of Sep 20 2024 21:00 BST.
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Vivos Therapeutics Inc | 14.02m | -12.05m | 10.95m | 114.00 | -- | 1.73 | -- | 0.7811 | -6.98 | -6.98 | 6.88 | 1.87 | 0.9477 | -- | 38.84 | 123,000.00 | -81.41 | -89.72 | -166.05 | -149.70 | 60.08 | 70.20 | -85.90 | -113.15 | -- | -- | 0.00 | -- | -13.87 | 29.48 | 43.04 | -- | -8.48 | -- |
| Scientific Industries Inc | 10.45m | -7.76m | 12.29m | 63.00 | -- | 1.05 | -- | 1.18 | -0.9231 | -0.9231 | 1.17 | 1.11 | 0.7343 | 1.13 | 9.08 | 165,942.90 | -54.50 | -- | -62.11 | -- | 45.41 | -- | -74.22 | -- | 3.15 | -- | 0.00 | -- | -- | -- | -- | -- | -- | -- |
| STRATA Skin Sciences Inc | 32.73m | -8.31m | 12.35m | 99.00 | -- | 1.09 | -- | 0.3772 | -2.37 | -2.37 | 9.35 | 2.71 | 0.6906 | 3.47 | 7.81 | 330,606.10 | -17.54 | -11.48 | -24.26 | -16.55 | 54.30 | 61.28 | -25.40 | -17.70 | 0.9176 | -2.69 | 0.6141 | -- | -7.75 | 2.24 | -95.17 | -- | 23.29 | -- |
| Dalrada Financial Corporation | 32.16m | -21.34m | 12.41m | 0.00 | -- | 1.41 | -- | 0.386 | -0.2388 | -0.2388 | 0.3573 | 0.091 | 1.09 | 8.86 | 3.37 | -- | -75.10 | -80.63 | -239.06 | -- | 30.11 | 39.23 | -68.78 | -63.94 | 1.24 | -21.54 | 0.3452 | -- | 54.35 | -- | -43.94 | -- | -- | -- |
| Applied DNA Sciences Inc | 3.40m | -7.52m | 12.46m | 53.00 | -- | 1.01 | -- | 3.67 | -11.86 | -11.86 | 2.18 | 1.20 | 0.2092 | 6.83 | 5.68 | 64,114.15 | -45.51 | -88.57 | -55.20 | -121.91 | 25.04 | 44.35 | -217.48 | -113.26 | 3.76 | -- | 0.00 | -- | -26.43 | 27.92 | -18.73 | -- | 33.80 | -- |
| QT Imaging Holdings Inc | 0.00 | -4.02m | 12.86m | -- | -- | 0.5917 | -- | -- | -0.3999 | -0.3999 | 0.00 | 1.01 | 0.00 | -- | -- | -- | -12.32 | -- | -16.60 | -- | -- | -- | -- | -- | -- | -- | 0.3042 | -- | -- | -- | -45.07 | -- | -- | -- |
| REMSleep Holdings Inc | 144.88k | -1.81m | 14.41m | 6.00 | -- | 25.06 | -- | 99.46 | -0.0012 | -0.0012 | 0.0001 | 0.0004 | 0.08 | 1.69 | 4.75 | -- | -99.82 | -152.40 | -122.32 | -317.98 | -491.08 | -- | -1,246.94 | -2,317.52 | 1.47 | -43.58 | 0.1207 | -- | -36.48 | -- | 12.13 | -- | 28.26 | -- |
| Trinity Biotech plc (ADR) | 58.65m | -22.29m | 14.55m | 380.00 | -- | -- | -- | 0.2482 | -2.74 | -2.74 | 7.23 | -19.24 | 0.7052 | 1.69 | 3.74 | 154,347.40 | -26.80 | -20.30 | -35.44 | -29.54 | 34.28 | 39.92 | -38.01 | -29.86 | 0.8936 | -2.16 | 1.46 | -- | -9.10 | -10.15 | 15.41 | -- | -31.08 | -- |
| Autonomix Medical Inc | -100.00bn | -100.00bn | 15.01m | 5.00 | -- | 2.37 | -- | -- | -- | -- | -- | 0.2749 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.1647 | -- | -- | -- | -674.99 | -- | -- | -- |
| LiveCare Inc | 0.00 | -2.34m | 15.26m | -- | -- | 6.47 | -- | -- | -0.1411 | -0.1411 | 0.00 | 0.0463 | 0.00 | -- | -- | -- | -424.83 | -- | -550.62 | -- | -- | -- | -- | -- | -- | -8.18 | 0.1888 | -- | -- | -- | -344.86 | -- | -- | -- |
| Cutera Inc | 169.19m | -148.97m | 15.50m | 430.00 | -- | -- | -- | 0.0916 | -7.46 | -7.46 | 8.46 | -10.73 | 0.4572 | 2.08 | 3.86 | 393,460.50 | -40.25 | -22.00 | -51.64 | -30.72 | 8.18 | 47.63 | -88.05 | -27.24 | 2.17 | -31.34 | 2.05 | -- | -15.86 | 5.47 | -97.76 | -- | 85.87 | -- |
| Innovative Eyewear Inc | 1.53m | -7.86m | 15.53m | 11.00 | -- | 2.06 | -- | 10.15 | -11.01 | -11.01 | 2.05 | 4.81 | 0.1779 | 1.97 | 15.91 | 139,070.90 | -91.45 | -- | -96.06 | -- | -2.46 | -- | -514.10 | -- | 12.85 | -- | 0.00 | -- | 74.67 | -- | -17.28 | -- | -- | -- |
| BioRegenx Inc | 634.81k | -727.95k | 17.12m | 10.00 | -- | 1.01 | -- | 26.97 | -0.001 | -0.001 | 0.0016 | 0.0178 | 0.0617 | -- | -- | 63,481.00 | -7.07 | -- | -8.46 | -- | 74.90 | -- | -114.67 | -- | 0.1547 | -8.80 | 0.0977 | -- | -47.25 | -- | -629.37 | -- | -- | -- |
| PAVmed Inc | 3.83m | -67.35m | 17.17m | 107.00 | -- | -- | -- | 4.48 | -8.17 | -8.17 | 0.4595 | -7.74 | 0.0823 | -- | 29.45 | 35,785.05 | -155.93 | -154.56 | -- | -1,152.82 | -77.59 | -- | -1,895.64 | -8,764.89 | 0.5529 | -8.16 | 1.74 | -- | 550.40 | -- | 25.76 | -- | 55.51 | -- |
| Beyond Air Inc | 1.78m | -58.35m | 17.78m | 107.00 | -- | 1.09 | -- | 9.97 | -1.65 | -1.65 | 0.0485 | 0.3514 | 0.0298 | 1.70 | 6.87 | 16,663.55 | -104.22 | -78.25 | -137.64 | -99.91 | -78.30 | -- | -3,493.78 | -6,152.99 | 2.42 | -38.11 | 0.4666 | -- | -- | -31.57 | -7.93 | -- | 152.05 | -- |
Data as of Sep 20 2024. Currency figures normalised to Trinity Biotech PLC's reporting currency: US Dollar USD
27.97%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Perceptive Advisors LLCas of 30 Jun 2024 | 1.80m | 19.02% |
| Hunter Associates Investment Management LLCas of 30 Jun 2024 | 333.71k | 3.53% |
| Renaissance Technologies LLCas of 30 Jun 2024 | 265.45k | 2.80% |
| Whitefort Capital Management, LPas of 30 Jun 2024 | 81.90k | 0.87% |
| Acadian Asset Management LLCas of 30 Jun 2024 | 72.11k | 0.76% |
| Moss Adams Wealth Advisors LLCas of 30 Jun 2024 | 25.67k | 0.27% |
| Cambridge Investment Research Advisors, Inc.as of 30 Jun 2024 | 22.28k | 0.24% |
| Becker Capital Management, Inc.as of 30 Jun 2024 | 18.00k | 0.19% |
| Virtu Americas LLCas of 30 Jun 2024 | 14.27k | 0.15% |
| Citadel Securities LLCas of 30 Jun 2024 | 14.15k | 0.15% |
More ▼
Data from 30 Jun 2024 - 30 Jun 2024Source: FactSet Research Systems Inc.
